Page 8 - Roots Analysis News Today

With Number Of Depression Cases Rising, Psilocybin Medicines Are Being Rapidly Accepted - Financialnewsmedia.com News Commentary PALM BEACH, Fla., April 22, 2021 /PRNewswire/ -- Global Psychedelic and Psilocybin Drugs market is growing rapidly due to the increasing number of depression cases and rising special designation from the regulatory authorities to the company to expedite the development process of medicines. Psychedelic Medicines also called as hallucinogenics, are a group of substance...

6 Min Read (Reuters) - The success of COVID-19 vaccines based on messenger RNA (mRNA) is smoothing the way for using the novel technology not only in other vaccines, but possibly as treatments for cystic fibrosis, cancer and other hard-to-treat diseases. FILE PHOTO: A scientist conducts research on a vaccine for the novel coronavirus (COVID-19) at the laboratories of RNA medicines company Arcturus Therapeutics in San Diego, California, U.S., March 17, 2020. REUTERS/Bing Guan/File Photo Scientis...

Roots Analysis Real World Evidence - Stakeholder Need Analysis In modern healthcare, the applications of real world data-based insights are vast, ranging from drug discovery to supporting regulatory decision-making LONDON, UNITED KINGDOM, March 3, 2021 /EINPresswire.com/ -- Roots Analysis has announced the addition of “Pharmaceutical and Life Sciences Real World Evidence Market, (2nd Edition), 2021-2030” report to its list of offerings. The digitization of data and advances in information p...

iCrowdNewswire   Mar 3, 2021  2:30 AM ET In modern healthcare, the applications of real world data-based insights are vast, ranging from drug discovery to supporting regulatory decision-making; in fact, the US FDA routinely uses real world evidence to monitor post market safety of drugs Roots Analysis has announced the addition of “Pharmaceutical and Life Sciences Real World Evidence Market, (2nd Edition), 2021-2030” report to its list of offerings. The digitization of data and advances...

MRNA as a therapeutic / preventive agent has been demonstrated to be well tolerated & can harness the cell’s translational machinery to invoke immune responses

Gene Therapies Market Driven by the potential treat the root cause of diseases, the gene therapies pipeline is growing, and the market anticipated to witness substantial growth Success of approved gene therapies has resulted in a surge in interest of biopharmaceutical developers in this rapidly evolving domain. Presently, the ability of gene therapies to treat diverse disease indications is considered among the most prominent drivers of this market. In addition, promising clinical results of pi...

Over 100 CMOs presently claim to offer manufacturing services for antibodies The antibody contract manufacturing market is currently dominated by the presence of small and mid-sized companies, which represent 70% of the industry stakeholders. It is also worth highlighting that more than 55% of CMOs claim to have the capabilities to manufacture antibodies across all scales of operation (preclinical, clinical and commercial). More than 90% service providers are focused on the production of monoc...